A detailed history of Procyon Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Procyon Advisors, LLC holds 56,147 shares of PFE stock, worth $1.48 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
56,147
Previous 55,818 0.59%
Holding current value
$1.48 Million
Previous $1.56 Million 4.04%
% of portfolio
0.11%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$27.7 - $31.39 $9,113 - $10,327
329 Added 0.59%
56,147 $1.62 Million
Q2 2024

Aug 02, 2024

SELL
$25.26 - $29.6 $80,377 - $94,187
-3,182 Reduced 5.39%
55,818 $1.56 Million
Q1 2024

Apr 15, 2024

SELL
$25.89 - $29.73 $80,543 - $92,490
-3,111 Reduced 5.01%
59,000 $1.64 Million
Q4 2023

Jan 18, 2024

SELL
$26.13 - $33.94 $431,772 - $560,824
-16,524 Reduced 21.01%
62,111 $1.79 Million
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $1.07 Million - $1.25 Million
33,196 Added 73.06%
78,635 $2.61 Million
Q2 2023

Jul 17, 2023

BUY
$36.12 - $41.79 $525,654 - $608,169
14,553 Added 47.12%
45,439 $1.67 Million
Q1 2023

Apr 10, 2023

BUY
$39.39 - $51.28 $101,311 - $131,892
2,572 Added 9.08%
30,886 $1.26 Million
Q4 2022

Jan 19, 2023

BUY
$41.75 - $54.5 $228,122 - $297,788
5,464 Added 23.91%
28,314 $0
Q3 2022

Oct 17, 2022

SELL
$43.76 - $53.42 $84,850 - $103,581
-1,939 Reduced 7.82%
22,850 $1 Million
Q2 2022

Jul 11, 2022

SELL
$46.53 - $55.17 $136,286 - $161,592
-2,929 Reduced 10.57%
24,789 $1.3 Million
Q1 2022

Apr 18, 2022

BUY
$45.75 - $56.69 $14,868 - $18,424
325 Added 1.19%
27,718 $1.44 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $101,523 - $150,491
-2,457 Reduced 8.23%
27,393 $1.62 Million
Q3 2021

Oct 14, 2021

SELL
$39.25 - $50.42 $341,004 - $438,048
-8,688 Reduced 22.54%
29,850 $1.28 Million
Q2 2021

Jul 22, 2021

BUY
$35.91 - $40.68 $823,631 - $933,036
22,936 Added 147.01%
38,538 $1.51 Million
Q1 2021

Apr 29, 2021

SELL
$33.49 - $37.77 $7,032 - $7,931
-210 Reduced 1.33%
15,602 $565,000
Q4 2020

Jan 19, 2021

BUY
$33.47 - $42.56 $71,056 - $90,354
2,123 Added 15.51%
15,812 $582,000
Q3 2020

Oct 22, 2020

BUY
$31.75 - $37.25 $59,213 - $69,471
1,865 Added 15.77%
13,689 $502,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $42,800 - $51,923
1,421 Added 13.66%
11,824 $387,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $27,138 - $38,774
-1,004 Reduced 8.8%
10,403 $340,000
Q4 2019

Feb 21, 2020

BUY
$32.92 - $37.36 $375,518 - $426,165
11,407 New
11,407 $447,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.